Calumet, Inc. (CLMT)
NASDAQ: CLMT · Real-Time Price · USD
47.75
+1.98 (4.33%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Calumet Revenue
Calumet had revenue of $1.45B in the quarter ending June 30, 2026, with 40.77% growth. This brings the company's revenue in the last twelve months to $4.59B, up 12.80% year-over-year. In the year 2025, Calumet had annual revenue of $4.14B, down -1.25%.
Revenue (ttm)
$4.59B
Revenue Growth
+12.80%
P/S Ratio
0.91
Revenue / Employee
$2,981,494
Employees
1,540
Market Cap
4.20B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.14B | -52.30M | -1.25% |
| Dec 31, 2024 | 4.19B | 8.40M | 0.20% |
| Dec 31, 2023 | 4.18B | -505.30M | -10.78% |
| Dec 31, 2022 | 4.69B | 1.54B | 48.87% |
| Dec 31, 2021 | 3.15B | 879.80M | 38.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cabot | 3.63B |
| H.B. Fuller Company | 3.51B |
| Avient | 3.33B |
| Quaker Chemical | 1.98B |
| Ashland | 1.84B |
| Sensient Technologies | 1.70B |
| Ingevity | 1.16B |
| Hawkins | 1.11B |
CLMT News
- 4 days ago - Calumet price target raised to $47 from $26 at UBS - TheFly
- 4 days ago - Calumet to Attend Barclays Annual Energy-Power Conference - PRNewsWire
- 11 days ago - Calumet price target raised to $45 from $40 at Goldman Sachs - TheFly
- 13 days ago - Calumet price target raised to $40 from $34 at TD Cowen - TheFly
- 19 days ago - Calumet price target raised to $45 from $38 at BofA - TheFly
- 22 days ago - Calumet Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - Calumet Slides: Q2 2026 - Filings
- 22 days ago - Calumet Earnings release: Q2 2026 - Filings